DeNovix receives Japanese patent for its automated cell counter
DeNovix Inc. announces that the CellDrop™ Automated Cell Counter has been granted a patent by the Japanese Patent Office
DeNovix Inc. announces that the CellDrop™ Automated Cell Counter has been granted a patent by the Japanese Patent Office
New myTXTL bulk packaging aligns with volumes required for high-throughput organizations in synthetic biology
New Rxi-65TG columns promise accurate, reliable GC analysis with excellent thermal stability
Rugged long-life ESI electrodes provide equivalent LC-MS/MS performance to OEM electrodes over significantly longer lifetimes
The new software enhancements offer a complete application for CMC decision support, improvements for analytical data processing and analysis, and a move to 64-bit architecture
The Thermo Scientific 3900 Series environmental chambers mimic light, temperature and humidity conditions in line with regulatory requirements
AstraZeneca BioPharmaceuticals R&D has invested in a LyoConstellationTM S10 freeze dryer intended to help drive research and development of small scale GMP production.
Obtain reproducible assay results by automating key western blotting steps
This release builds extensively on the Mountains® 7 platform introduced in 2013 and now supplied by most major manufacturers with their instruments
New HCP detection kits are designed to detect the presence of host cell protein impurities at any phase of your therapeutic development
Analytik has launched a range of benchtop time-domain nuclear magnetic resonance (TD-NMR) systems
The DrySyn range is designed to enable laboratories around the world to undertake clean, safe synthetic reactions both individually or in parallel
Trial successfully identifies people with advanced non-small cell lung cancer for treatment with Alecensa
Making high-value chemicals requires many years and large financial investment
X-Pulse offers capabilities previously available only on complex and expensive high-field NMR spectrometers
A pioneering commercialized fluorescence-based flow cytometry platform
Roche's Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer
The company launched the platform at the SynBioBeta 2019 conference in San Francisco
Women with a rare type of ovarian cancer could benefit from a drug that quadruples the likelihood of response compared with standard therapies
Rigaku is attending the 2019 Materials Science and Technology meeting to present it's latest X-ray analytical instrumentation
AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy.
Uniqsis offers an extensive range of individual flow chemistry modules that can be used on any flow chemistry system